Short- and long-term outlook after emergency admission for acute heart failure
Official title: Short and Long Term Prognosis of Patients Admitted to the Emergency Department With Acute Heart Failure
Run by University of Monastir · NCT03806972 · Data updated 2026-11-12
This project will try to see how people admitted to the emergency department with acute heart failure do at 30 days and one year, comparing those with reduced versus preserved ejection fraction.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 80 Years |
| Sex | All |
| Enrollment | 3000 (estimated) |
| Sponsor | University of Monastir Academic / other |
| Locations | 1 site (Monastir, Monastir Governorate) |
| Status | Recruiting |
| Started | June 1, 2009 |
| Main results expected | December 1, 2030 |
| Study ends | December 1, 2030 |
| Registry record updated | July 22, 2025 |
| Trial ID | NCT03806972 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults admitted to the Emergency Department at the University of Monastir with a primary discharge diagnosis of acute heart failure who can consent and comply with follow-up.
✕Probably not a fit
Patients who are pregnant or breastfeeding, those with altered consciousness or requiring immediate mechanical or ventilatory support, or those unable to comply with follow-up are excluded and unlikely to benefit from this observational work.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is an observational cohort of adults admitted to the Emergency Department at the University of Monastir with a primary discharge diagnosis of acute heart failure. Patients will be classified as heart failure with reduced ejection fraction (HFrEF) or preserved ejection fraction (HFpEF) and baseline clinical data will be recorded. The main outcomes are mortality and rehospitalization at 30 days and one year, determined through clinic follow-up and medical record review. Pregnant or breastfeeding patients, those with altered consciousness or needing immediate mechanical/hemodynamic/ventilatory support, and individuals unable to comply with follow-up are excluded and no interventional treatments are assigned.
Why it matters
Potential benefit: If successful, the results could help clinicians predict which emergency-admitted heart failure patients are at higher short- and long-term risk and improve follow-up and care planning.
How similar studies have gone: Many prior observational studies have compared outcomes between HFrEF and HFpEF, so this project builds on an established evidence base rather than introducing a novel treatment.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * patients admitted to the ED of Monastir with a principal discharge diagnosis code for HF. Exclusion Criteria: * Pregnant or breast feeding women. Alteration of consciousness GCS \< 15 Critically ill patients needing immediate mechanical hemodynamic of ventilatory support. Inability to follow instructions or comply with follow-up procedures.
Where it's running
-
Emergency Departement
Monastir, Monastir Governorate, Tunisia Recruiting
Study contacts
- Principal investigator: Nouira Semir, Professor — university Hospital of Monastir
- Study coordinator: Nouira Semir, Professor
- Email: semir.nouira@rns.tn
- Phone: 73106000
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Infusion of furosemide to see if a loading infusion helps remove fluid better in acute heart failure
This study tests whether giving furosemide as a continuous infusion with a loading dose is better at removing excess fluid than giving it as bolus injections in adults with acute heart failure.
-
Characterizing phenotypes of acute heart failure
This project will try to see if heart function measures, imaging features (radiomics), and blood biomarkers can predict outcomes for adults hospitalized with acute heart failure, including cardiogenic shock.
-
Early finerenone treatment for hospitalized adults with acute heart failure and LVEF ≥40%
This trial will test whether starting finerenone early during hospitalization helps adults with acute heart failure who have a left ventricular ejection fraction of 40% or higher.
-
Intensive GDMT optimization for women after heart failure hospitalization
This study tests whether rapidly increasing and closely monitoring heart failure meds in women after hospitalization can reduce death or readmission within a year.
-
Using intra‑abdominal pressure and bedside ultrasound to guide decongestive treatment in heart failure
This trial will test whether using bladder pressure (intra‑abdominal pressure) measurements together with bedside ultrasound to guide IV loop diuretics helps people hospitalized with acute heart failure get rid of excess fluid more effectively than usual care.
-
Investigating heart issues in COPD patients during hospital stays
This study is trying to see if sudden worsening of COPD can cause heart problems in hospitalized patients and how it affects their recovery.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.